Literature DB >> 12154200

Beauty and the beast. The nitric oxide paradox in systemic sclerosis.

M Matucci Cerinic, M B Kahaleh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12154200     DOI： 10.1093/rheumatology/41.8.843

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  28 in total

1.  Nailfold capillaroscopy assessment of microcirculation abnormalities and endothelial dysfunction in children with primary or secondary Raynaud syndrome.

Authors:  Joanna Latuskiewicz-Potemska; Antonina Chmura-Skirlinska; Ryszard J Gurbiel; Elzbieta Smolewska
Journal:  Clin Rheumatol       Date:  2016-06-29       Impact factor: 2.980

2.  Current Treatment Options in Raynaud's Phenomenon.

Authors:  Sergio Generini; Angela Del Rosso; Alberto Pignone; Marco Matucci Cerinic
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-04

Review 3.  The association between systemic sclerosis, arginine and asymmetric dimethylarginine.

Authors:  Li Zhang; Ya-Nan Wan; Jiu-Hua Zhao; Yu-Jie Wang; Ying-Xin Wang; Jun-Wei Yan; Xiao-Lei Huang; Jing Wang
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

4.  Autoantibody against caspase-3, an executioner of apoptosis, in patients with systemic sclerosis.

Authors:  Shihoko Okazaki; Fumihide Ogawa; Yohei Iwata; Toshihide Hara; Eiji Muroi; Kazuhiro Komura; Motoi Takenaka; Kazuhiro Shimizu; Minoru Hasegawa; Manabu Fujimoto; Shinichi Sato
Journal:  Rheumatol Int       Date:  2009-07-29       Impact factor: 2.631

5.  Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis.

Authors:  Valeria Riccieri; Antonio Spadaro; Leos Fuksa; Omidreza Firuzi; Luciano Saso; Guido Valesini
Journal:  Clin Rheumatol       Date:  2007-10-27       Impact factor: 2.980

6.  Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosis.

Authors:  Matthieu Roustit; Grant H Simmons; Jean-Philippe Baguet; Patrick Carpentier; Jean-Luc Cracowski
Journal:  J Rheumatol       Date:  2008-06-15       Impact factor: 4.666

7.  Involvement of gaseous low molecular monoxides in the cutaneous reverse passive Arthus reaction: cytoprotective action of carbon monoxide.

Authors:  K Shimizu; S J Bae; T Hara; Y Iwata; T Yamaoka; K Komura; E Muroi; M Takenaka; F Ogawa; S Sato
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

8.  Serum nitric oxide metabolites and disease activity in patients with systemic sclerosis.

Authors:  Mo Yin Mok; Peter Chin Wah Fung; Clara Ooi; Hung Fat Tse; Yik Wong; Yui Ming Lam; Woon Sing Wong; Chak Sing Lau
Journal:  Clin Rheumatol       Date:  2007-08-15       Impact factor: 2.980

9.  Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control.

Authors:  Alberto Pignone; Angela Del Rosso; K Bridget Brosnihan; Federico Perfetto; Riccardo Livi; Ginevra Fiori; Serena Guiducci; Marina Cinelli; Veronica Rogai; Alessio Tempestini; Francesca Bartoli; Sergio Generini; Carlos M Ferrario; Marco Matucci Cerinic
Journal:  Ann Rheum Dis       Date:  2007-03-14       Impact factor: 19.103

10.  Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis.

Authors:  A Servettaz; P Guilpain; C Goulvestre; C Chéreau; C Hercend; C Nicco; L Guillevin; B Weill; L Mouthon; F Batteux
Journal:  Ann Rheum Dis       Date:  2007-03-15       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.